ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Phenomenex to join Danaher portfolio

by Marc S. Reisch
October 17, 2016 | APPEARED IN VOLUME 94, ISSUE 41

Danaher will acquire Phenomenex, a maker of chromatography columns with about 700 employees. The acquisition is intended to strengthen the instrumentation and consumables portfolio of the industrial conglomerate. Financial details were not disclosed, but Goldman Sachs estimates that Phenomenex has annual sales of about $200 million. Danaher says Phenomenex will continue to operate as a stand-alone company once the deal closes later this year. Other Danaher-owned instrument firms include Sciex, Beckman Coulter Life Sciences, and Molecular Devices.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment